Dosage & Administration

For subcutaneous use only

The recommended rHuPH20 dose is 80 U/g Immune globulin G (IgG), which corresponds to 0.5 mL rHuPH20 solution per 10 mL Immune Globulin Infusion 10% (Human) solution for both indications.

PI

Initiation of Treatment with HYQVIA

Switching from Immune Globulin Intravenous (Human) [IGIV] treatment:


Naïve to Immune Globulin Subcutaneous (Human) [IGSC] treatment or switching from IGSC treatment:


CIDP

Switching from Immune Globulin Intravenous (Human) [IGIV] treatment:


Get Your Patient on HyQvia

See your patient's specific prior authorization requirements including coverage restrictions and step therapies
Or select your Insurance from the list below:

HyQvia Prescribing Information

HyQvia Prior Authorization Resources

Most recent state uniform prior authorization forms

Benefits investigation

HyQvia Financial Assistance Options

Copay savings program

View more

HyQvia PubMed™ News

    HyQvia Patient Education

    Getting started on HyQvia

    Patient toolkit

    HyQvia FAQs